Canada NewsPharmacyclics’ Leukemia Drug Beats Glaxo’s in TrialBloombergPharmacyclics Inc. (PCYC)’s Imbruvica, introduced this year for chronic lymphocytic leukemia, helped patients live longer without their disease worsening than GlaxoSmithKline Plc (GSK)’s treatment for the blood cancer. In a head-to-head comparison, 391 …Drug Improves Survival of LeukemiaWKRB NewsPharmacyclics’ Leukemia drug treats better than Glaxo’sDelhi Daily NewsImbruvica : Drug Improves Survival of LeukemiaCanada NewsBioWorld Online -MSN Money -WRCB-TVall 21 news articles …Read Full Story
Pharmacyclics' Leukemia Drug Beats Glaxo's in Trial - Bloomberg
Real Estate of Cebu
